Form 4 Filing for Jeff E. Knight at ALX ONCOLOGY HOLDINGS INC

This filing reports a Form 4 for Jeff E. Knight, Chief Dev & Operating Officer at ALX ONCOLOGY HOLDINGS INC. On April 16, 2026, Mr. Knight acquired 800,000 stock options to purchase common stock at a price of $0.0 per share. These options have an exercise price of $1.68 and expire on April 15, 2036. The options vest over time, with one-fourth vesting on April 13, 2027, and the remainder vesting monthly thereafter. Following this transaction, Mr. Knight owns 800,000 shares of common stock underlying these options.